Skip to main content
. 2019 Dec 14;11(12):680. doi: 10.3390/pharmaceutics11120680

Figure 3.

Figure 3

Viability of BMDCs treated with RA/CTS polyplexes. Bone marrow-derived dendritic cells (BMDCs) were treated for 24 h with RA/CTS polyplexes formed with various molecular weights of CTS. The viability of BMDCs was examined using live-cell imaging (A) and MTT assay (B). Size bar: 50 μm. n.s.: not significantly different.